Carpmaels & Ransford LLP > London, England > Firm Profile

Carpmaels & Ransford LLP
ONE SOUTHAMPTON ROW
LONDON
WC1B 5HA
England

TMT (technology, media and telecoms) > PATMA: Patent attorneys Tier 1

Praised for its ‘sophisticated patent practice’, Carpmaels & Ransford LLP houses a ‘deep bench of skilled partners who work together collaboratively and seamlessly’. The firm excels in the pharmaceuticals and biotechnology sectors, advising on the full life cycle of a patent, from invention mining, drafting and prosecution work to enforcement matters. James Warner and Mark Chapman head up the pharmaceuticals and biotechnology teams respectively and managing partner Hugh Goodfellow is also a key contact in the life sciences group, while John Brunner, who has considerable EPO opposition experience relating to medical devices, leads the engineering and technology teams. Counting Johnson & Johnson, Sun Chemical and Nexeon among its key list of clients, the chemistry and materials practice handles chemical opposition mandates before the EPO and focuses on consumer product matters. All the teams are well-placed to leverage the firm’s litigation offering.

Practice head(s):

Hugh Goodfellow; John Brunner; Mark Chapman; James Warner

Other key lawyers:

Cameron Marshall; Daniel Wise; Harvey Adams; Edward Oates; Gary Small; Susan Kirsch; Bruce Cockerton; Stephen Duffield; Paul Bettridge; Chris Hoggett; Matthew Georgiou; Isobel Barry; Anna Leathley

Testimonials

‘Carpmaels is a tremendous firm with a sophisticated patent practice. I use them for all my patent work in prosecution and oppositions. They have a very deep bench of skilled partners who work together collaboratively and seamlessly. I have confidence in whoever I am working with.’

‘The team at Carpmaels have been very responsive to our business.’

‘Hugh Goodfellow is my primary contact and someone I have known for many years. He recently handled an opposition for us. It was a difficult case and we won in large part thanks to his preparation and advocacy skills. Stephen Duffield is another team member that we rely on. He is very thoughtful and a talented patent attorney.’

‘Working with the team at Carpmaels is amazing. They all seem to just flow with one another. Work doesn’t feel handed-off, but shared. All, of course, have superb knowledge of their domain.’

‘Great team, very enthusiastic and have a strong interest in our business succeeding.’

‘The team is super smart and creative. They are truly thought partners. When they bring a solution forward, they also demonstrate why they think that is the best path. It is obvious that they have debated the idea internally among the team and I feel confident with each step we take in the EPO and other proceedings and decisions being made.’

Key clients

Regeneron Pharmaceuticals, Inc.

Barclays Bank Plc

Incyte

Roche

Biogen Inc.

Johnson & Johnson Vision

Align Technology

Novartis

Vertex

Dupont Teijin Films

Gilead

Johnson & Johnson, with Boston Scientific

Jazz Pharmaceuticals

CSL

LifeScan, Inc.

Ethicon Inc. & Ethicon LLC

McNeil AB

Acorda Therapeutics

Biosense Webster

Abbott Laboratories

Raytheon Technologies Corporation

Janssen Pharmaceuticals

LEO Pharma

Afiniti, Ltd.

Auris Health/Verb Surgical

Quantum-Si

Amgen

Work highlights

  • Advising Johnson & Johnson on a number of opposition matters for European patents which are in litigation in the UK and German courts, involving the dispute between AMO and Alcon.
  • Advising Regeneron Pharmaceuticals, Inc. on production and processing matters, including instructions on approximately 50 European applications.
  • Representing Gilead Sciences, Inc. in protecting its HIV portfolio, which has been opposed by generics manufacturers.

TMT (technology, media and telecoms) > PATMA: Trade mark attorneys Tier 2

Carpmaels & Ransford LLP is noted for its capability in opposition and appeal proceedings before the UKIPO and EUIPO, as well as handling trade mark mandates ranging from clearance searches and registration to licensing and transactional matters. The prosecution and opposition practice frequently collaborates with the firm’s dedicated litigation group to weather the increasing number of instructions on contentious trade mark matters and disputes. Roger Lush leads the practice and Jonathan Day, who is dual-qualified as a trade mark attorney and solicitor, has experience in brand protection, enforcement and management issues, in addition to opposition cases and EU brand clearance. The team has demonstrable expertise across the media and entertainment, pharmaceuticals, consumer goods, technology, fashion and retail sectors. Senior associate and trade mark attorney Lara Elder is another key member of the team.

Practice head(s):

Roger Lush

Other key lawyers:

Key clients

Align Technology, Inc.

Bear Grylls Ventures LLP

Manzanita Capital

Allergan (Botox)

Hugo Boss

Deere & Company

Blue Prism AI

Western Digital

Biogen Idec.

Byredo

Diptyque

Space NK

Invisalign

XEROS

Marvel

Lucasfilm

National Geographic

20th Century

Penguin Random House

DN Management Ltd

Motorsport UK

Rajinder Sharma, Recup Ltd

Umarex GmbH

Celgene/Bristol-Myers Squibb

4D Pharma

Aphria

Compass Pathways

Takeda/ Shire Pharmaceuticals

De Beers

Space NK

Eve Lom

Diptyque

Malin + Goetz

Kevyn Aucoin

Susanne Kaufmann

Iris Nation

McArthurGlen

Belron

Polaroid

McIlhenny Company

Western Digital

Total

GAM Limited

RektGlobal, Inc

Cara Therapeutics

Kalvista

Pacific World Corporation

Work highlights

  • Assisting Allergan in relation to a worldwide trade mark and unfair competition dispute with litigation in several countries.
  • Assisting Bear Grylls Ventures with the expansion and defence of the Bear Grylls brand, including general counselling, portfolio management and prosecution of brand extension related filings pursuant to commercial partnerships and licence agreements.
  • Assisting Align in several disputes with third parties in Europe, who have adopted ALIGN or INVIS derivative marks for orthodontic products and services.

TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious) Tier 3

Carpmaels & Ransford LLP’s patent offering provides ‘an excellent joined up service for patent litigation’. Strong across patent prosecutions and litigation, the team has recently been involved in a number of cutting edge mandates related to SCPs for blockbuster drug production. Cross-border strategies for defence are also an area of strength for the team, which is led co-led by David Wilson and Jake Marshall. Wilson heads up the dispute resolution arm of the practice, in which Jennifer Antcliff and Ian Kirby shine. Marshall is the name for transactional and advisory matters, including licensing and manufacturing deals.

Practice head(s):

David Wilson; Jake Marshall

Other key lawyers:

Ian Kirby; Jennifer Antcliff; Camilla Balleny; Simon Llewellyn; Sarah Johnson; Simon Keevey-Kothari; Chloe Taylor

Testimonials

‘Jennifer Antcliff is one of the best patent litigators in London, ably supported by David Wilson and Camilla Balleny. Ian Kirby is a star.’

‘Sarah Johnson is diligent, bright and highly personable – she provides an excellent contribution to any team.’

‘C&R is unusual in having integrated teams of solicitors and patent attorneys, which enables them to provide a highly technically qualified team with a view of patent prosecution as well as litigation.’

‘Ian Kirby, David Wilson and Jennifer Antcliff are all excellent and astute litigators, supported by a number of able associates.’

‘Carpmaels provides a sense of intimacy and knowledge of our company’s patent portfolio and our corporate objectives. They bring the right level of effort and competency to every issue, whether prosecution, opposition, or litigation, and provide strategic guidance on the portfolio and various actions that make clear what path to take and more often than not results in the desired outcome.’

‘Every member of the Carpmaels team I have worked with is intelligent, engaged, and knowledgeable in the specific topics of importance to the project. They always make themselves available, almost regardless of the time of day, and each team member provides me with a sense of responsibility and diligence in providing appropriate guidance and answers to questions asked, or to pull in Carpmaels team members (or outside resources) to make sure I get the information I need.’

‘Ian Kirby is a strong leader and case manager who was always available and involved in the case on a day-to-day basis.’

Key clients

Bristol Myers Squibb

Janssen Pharmaceutica

Janssen Oncology

Novartis

Takeda

AMO Development, LLC

Ethicon, Inc.

FibroGen

BISSELL Homecare, Inc.

The LYCRA Company

Olympus Corporation

Harbour BioMed

Amgen Europe GmbH

Radius Health Inc

CSL Behring AG

Work highlights

  • Representing Johnson & Johnson subsidiary, AMO Development, LLC, in a multi patent revocation and infringement action commenced by Alcon in relation to AMO’s technology for laser eye surgery machinery.
  • Representing Bristol Myers Squibb’s patent estate covering its blockbuster product Revlimid.

Industry focus > Life sciences and healthcare Tier 4

Carpmaels & Ransford LLP’s ‘real strength across patent prosecution and opposition work’ benefits from the ‘highly technically qualified team’, which is ‘very collaborative and a pleasure to work with’. The group handles the full range of patent and trade mark mandates as well as advising on transactions and supplementary protection certificates (SPCs). Key individuals include managing partner Hugh Goodfellow, dispute resolution head David Wilson, IP transactional leader Jake Marshall, trade mark head Roger Lush, and James Warner and Mark Chapman, who lead the chemistry and pharmaceuticals, and biotechnology teams respectively.

Practice head(s):

Hugh Goodfellow; David Wilson; Jake Marshall; Roger Lush; James Warner; Mark Chapman

Other key lawyers:

Daniel Wise; Camilla Balleny; Richard Newell

Testimonials

‘C&R is unusual in having integrated teams of solicitors and patent attorneys, which enables them to provide a highly technically qualified team with a view of patent prosecution as well as litigation.’

‘We have worked closely with Jake Marshall on two complicated licensing deals over the last two years. In both occasions, Jake helped us successfully navigate through what were complicated agreements, reaching favourable terms. His knowledge of current market deal expectations was invaluable and helped greatly in delivering us the best deal.’

‘The Carpmaels team is very sophisticated and deep. They have a real strength across patent prosecution and opposition work. I use them for all my EP work and know that they will provide the highest quality work product both in terms of the legal analysis but also technical. They are creative and we consider them part of our team vs. a group that simply executes on our instructions. They are also very collaborative and a pleasure to work with.’

‘Hugh Goodfellow leads the group and is someone that we have known for many years. He did a wonderful job on a recent opposition matter that was particularly challenging — we won in large part thanks to his advocacy skills. He is also very generous in terms of promoting his partners.’

‘Carpmaels’ team members are highly educated within their technical field and can speak effectively and competently to relevant stakeholders at the company. At the agent, attorney, and solicitor level they are also very well educated with respect to the law. Both the partners and associates have depth of experience in both the technology and law, and clearly mentor more junior members of their team to provide a high level of professional rigor throughout the firm.’

‘Daniel Wise and Richard Newell are both top notch with respect to their knowledge of the chemical and biological sciences, their knowledge of the law, their personable natures, and their availability. They are honest and forthcoming with clear, targeted advice and provide detailed and thoughtful input on strategy and paths to overcoming obstacles. The team that supports them have these same traits, and work together in a very integrated and efficient fashion.’

‘The Team we work with – led by Mark Chapman – have been absolutely amazing. The depth of knowledge of legal matters combined with strength of understanding of cutting edge molecular biology is first rate.’

‘The team with whom we work is smart and true thought partners. When they bring issues to us, they begin with the recommendation, but then take a step back to show how they got there and what additional angles they evaluated. There is no stone left unturned.’

Key clients

Regeneron Pharmaceuticals, Inc.

Incyte

Biogen Inc.

Johnson & Johnson Vision

Align Technology

Novartis

Vertex

Gilead

Johnson & Johnson, with Boston Scientific

Jazz Pharmaceuticals

CSL

LifeScan, Inc.

Ethicon Inc. & Ethicon LLC

McNeil AB

Acorda Therapeutics

Biosense Webster

Abbott Laboratories

Raytheon Technologies Corporation

Janssen Pharmaceuticals

LEO Pharma

Afiniti, Ltd.

Auris Health / Verb Surgical

Quantum – Si

Amgen

Work highlights

  • Achieving an important victory for FibroGen, Inc., in which the Court of Appeal found that FibroGen’s patents were in fact valid on the ground of sufficiency, a decision with wider legal relevance.
  • Representing Johnson & Johnson subsidiary, AMO Development, LLC, in a multi patent revocation and infringement action commenced by Alcon in relation to AMO’s technology for laser eye surgery machinery.
  • Defending Bristol Myers Squibb’s patent estate covering its blockbuster product Revlimid.

Carpmaels & Ransford LLP is a leader in the European IP market, having driven innovation in the industry for over 200 years. The firm advises clients on all aspects of intellectual property including drafting, filing and prosecuting patent and trade mark applications, drafting and negotiating licence agreements and other commercial IP agreements, advising on the transfer of property rights, assisting clients with patent restoration matters and conducting enforcement and revocation litigation.

The firm has one of Europe’s largest intellectual property teams serving blue-chip clients across the globe, including Johnson & Johnson, Celgene, Novartis, Ionis Pharmaceuticals, Mars, Micron, Gilead, Raytheon, Regeneron, Takeda, Allergan and Xeros. The firm’s attorneys have considerable technical knowledge, bringing together experience from industry-leading companies, academic research at leading universities, and extensive patent expertise in the areas of engineering and tech, chemistry and materials, pharmaceuticals, biotechnology, supplementary protection certificates and information communications technology and standards.

Through the firm’s fully integrated dispute resolution and transactions teams, the firm is able to provide a holistic service for clients which supports their IP needs from inception to commercialisation. The dispute resolution team, comprised of experienced solicitors, barristers and patent attorney litigators, represents clients at all levels of the European Patent Office (EPO).The team is also adept at conducting enforcement litigation and revocation actions before the UK Intellectual Property Office (UKIPO) and patent, copyright, trade mark and other IP litigation in the English courts and the Court of Justice of the European Union, often advising in cases where parallel or related litigation is ongoing in courts across Europe or in the United States.

The transactions team is another key part of the firm’s integrated IP offering. As well as advising on the acquisition and licensing of IP rights, and other IP focused agreements, (such as development and collaboration agreements), the team manages multi-jurisdictional patent/trade mark assignment recordal projects, provides specialist advice on the transfer of priority rights and assists clients with the restoration of registered IP rights around the world.

DepartmentNameEmailTelephone
Managing partner Hugh Goodfellow
Chemistry Gillian McGuire
Dispute resolution David Wilson
Engineering and technology Gary Small
Life sciences Hugh Goodfellow
Trade marks Roger Lush
Transactions Jake Marshall
PhotoNamePositionProfile
Harvey Adams photo Harvey AdamsHarvey is a partner focussing on the Life Sciences and Chemistry sectors.…
Jennifer Antcliff photo Jennifer AntcliffJenny is a partner in the firm’s Dispute Resolution team. Her patent…
Camilla Balleny photo Camilla BallenyCamilla is a partner in the Dispute Resolution team. She has focussed…
Isobel Barry photo Isobel BarryIsobel advises innovator pharmaceutical companies through all stages of the pharmaceutical product…
Paul Bettridge photo Paul BettridgePaul sits within our Engineering and Tech teams, predominantly working within the…
John Brunner photo John BrunnerJohn has extensive experience working within the tech sector, with one of…
Mark Chapman photo Mark ChapmanMark leads the Biotechnology team at Carpmaels & Ransford. Mark’s impressive Biotech-only…
Bruce Cockerton photo Bruce CockertonBruce’s chemistry practice covers both industrial and medicinal chemistry, encompassing polymer chemistry, apparel…
Jonathan Day photo Jonathan DayJonathan is dual-qualified as a solicitor and trademark attorney. His background in…
Stephen Duffield photo Stephen DuffieldStephen’s work has a particular focus on biological therapies, often contentious and…
Matthew Georgiou photo Matthew GeorgiouMatthew is a Partner in the Life Sciences group. Matthew spends the…
Hugh Goodfellow photo Hugh GoodfellowHugh is the Managing Partner at Carpmaels & Ransford and a Partner…
Chris Hoggett photo Chris HoggettChris’ practice is in the pharmaceutical area of life sciences. He handles…
David Holland photo David HollandDavid is a partner in the Life Sciences group and has a…
Ian Kirby photoMr Ian KirbyIan is a Partner in the Dispute Resolution team and focuses on…
Susan Kirsch photoDr Susan KirschSusan is a Partner in the Chemistry team at Carpmaels & Ransford.…
Anna Leathley photo Anna LeathleyAnna’s area of expertise is in biotech. She has a current focus…
Roger Lush photo Roger LushRoger’s extensive and varied practice covers the full trade mark life-cycle, from…
Jake Marshall photo Jake MarshallJake specialises in transactional and advisory matters involving intellectual property and technology.…
Cameron Marshall photo Cameron MarshallCameron focuses exclusively on the biotechnology and pharmaceutical fields, with an extensive…
Gillian Mcguire photo Gillian McguireGill leads the Chemistry team at Carpmaels & Ransford. Gill has a…
Edward Oates photo Edward OatesEd practises in the life sciences field, with a particular focus on…
Gary Small photoDr Gary SmallGary leads the Engineering and Tech groups at Carpmaels & Ransford. He…
Chris Tunstall photo Chris TunstallAs a partner within the Engineering and Tech groups, Chris handles a…
James Warner photo James WarnerJames leads the Pharmaceuticals team at Carpmaels & Ransford. His practice focuses…
David Wilson photo David WilsonDavid leads the Dispute Resolution team at Carpmaels & Ransford and has…
Daniel Wise photo Daniel WiseDaniel specialises in biologics and pharmaceuticals, with particular expertise in protein therapeutics,…
Number of UK partners : 27
Number of other UK fee-earners : 96